Biocon reports robust Q2 FY24 results with a 49.26% YoY increase in revenue. The company witnesses an impressive growth of 167.8% YoY in net profit.
QoQ, Biocon shows a moderate 1.16% increase in revenue and a substantial 23.87% growth in profit. Selling, general, and administrative expenses rise by 7.44% QoQ and 15.2% YoY, showcasing continued investment.
Despite a 7.88% QoQ decline, the operating income sees a strong 47.29% YoY growth. Earnings per share (EPS) for Q2 FY24 stand at Rs 1.21, marking a significant 151.45% YoY increase.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
